Bette  Caan  to  Anti-Inflammatory Agents, Non-Steroidal
                            
                            
                                This is a "connection" page, showing publications  Bette  Caan  has written about  Anti-Inflammatory Agents, Non-Steroidal.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.939
         
        
        
     
 
    
        
        - 
            NSAIDs and breast cancer recurrence in a prospective cohort study. Cancer Causes Control. 2007 Aug; 18(6):613-20.
            
            
                Score: 0.265
            
         
        
        - 
            Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants. JAMA. 2015 Mar 17; 313(11):1133-42.
            
            
                Score: 0.115
            
         
        
        - 
            COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations. Cancer Causes Control. 2013 Dec; 24(12):2059-75.
            
            
                Score: 0.105
            
         
        
        - 
            Leptin and leptin receptor genotypes and colon cancer: gene-gene and gene-lifestyle interactions. Int J Cancer. 2008 Apr 01; 122(7):1611-7.
            
            
                Score: 0.071
            
         
        
        - 
            Transcription factor 7-like 2 polymorphism and colon cancer. Cancer Epidemiol Biomarkers Prev. 2008 Apr; 17(4):978-82.
            
            
                Score: 0.071
            
         
        
        - 
            Statin use and risk of prostate cancer in the California Men's Health Study cohort. Cancer Epidemiol Biomarkers Prev. 2007 Nov; 16(11):2218-25.
            
            
                Score: 0.069
            
         
        
        - 
            Association of fluids from beverages with risk of rectal cancer. Nutr Cancer. 2004; 49(1):25-31.
            
            
                Score: 0.053
            
         
        
        - 
            Non-steroidal anti-inflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States). Cancer Causes Control. 2003 Jun; 14(5):403-11.
            
            
                Score: 0.051
            
         
        
        - 
            Lifestyle and colon cancer: an assessment of factors associated with risk. Am J Epidemiol. 1999 Oct 15; 150(8):869-77.
            
            
                Score: 0.039
            
         
        
        - 
            Genetic variation in the lipoxygenase pathway and risk of colorectal neoplasia. Genes Chromosomes Cancer. 2013 May; 52(5):437-49.
            
            
                Score: 0.025
            
         
        
        - 
            Migraine history and breast cancer risk among postmenopausal women. J Clin Oncol. 2010 Feb 20; 28(6):1005-10.
            
            
                Score: 0.020
            
         
        
        - 
            Tumor markers and rectal cancer: support for an inflammation-related pathway. Int J Cancer. 2009 Oct 01; 125(7):1698-704.
            
            
                Score: 0.020
            
         
        
        - 
            Colon tumor mutations and epigenetic changes associated with genetic polymorphism: insight into disease pathways. Mutat Res. 2009 Jan 15; 660(1-2):12-21.
            
            
                Score: 0.018
            
         
        
        - 
            IL6 genotypes and colon and rectal cancer. Cancer Causes Control. 2007 Dec; 18(10):1095-105.
            
            
                Score: 0.017